Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis.

@article{Potter2006PhotodynamicTF,
  title={Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis.},
  author={Michael J. Potter and Shelagh M Szabo and David Sarraf and Rike Michels and Ursula M Schmidt-Erfurth},
  journal={Canadian journal of ophthalmology. Journal canadien d'ophtalmologie},
  year={2006},
  volume={41 1},
  pages={34-7}
}
BACKGROUND Photodynamic therapy (PDT) with verteporfin is now the standard of care worldwide for the treatment of choroidal neovascularization, but has been used only rarely in those with subretinal neovascular membranes (SRNVM) due to type 2A idiopathic juxtafoveolar retinal telangiectasis (IJT). We performed a retrospective study to examine the outcome of patients treated with PDT for SRNVM secondary to IJT. METHODS Retrospective interventional case series of 7 eyes of 6 IJT patients with… CONTINUE READING